Advertisement
Screener

uniQure N.V. (QURE) Other Current Liabilities

2.8 / 5 stars · 68/120 Roast Me

uniQure N.V. Other Current Liabilities

uniQure N.V. (QURE) had Other Current Liabilities of $2.25 million as of 2023-03-31, per its 10-Q filed 2023-05-09.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:OtherLiabilitiesCurrent · last filed 2024-02-28

  • 2023-03-31: Other Liabilities, Current $2.25M.
  • 2022-12-31: Other Liabilities, Current $2.25M.
  • 2021-12-31: Other Liabilities, Current $2.87M.
  • 2021-03-31: Other Liabilities, Current $5.00M.
Period endOther Liabilities, CurrentOther Liabilities, Current as first filed
2023-03-31$2.25M
10-Q · filed 2023-05-09
2022-12-31$2.25M
10-K · filed 2024-02-28
2021-12-31$2.87M
10-K · filed 2023-02-27
2021-03-31$5.00M
10-Q · filed 2021-05-10
2020-12-31$2.08M
10-Q · filed 2021-07-26
2018-12-31$545.00K
10-K · filed 2020-03-02
2018-09-30$836.00K
10-Q · filed 2018-11-06
2018-06-30$861.00K
10-Q · filed 2018-08-08
2018-03-31$440.00K
10-Q · filed 2018-04-30
2017-12-31$844.00K
10-K · filed 2019-02-28
2017-09-30$2.45M
10-Q · filed 2017-11-01
2017-06-30$2.37M
10-Q · filed 2017-08-08
2017-03-31$30.00K
10-Q · filed 2017-05-09
2016-12-31$383.00K
10-K · filed 2018-03-14
$57.00K
10-K · filed 2017-03-15
2015-12-31$574.00K
10-K · filed 2017-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34